Global Presence in 31 Countries 

Strategic Global IP Protection

A robust patent portfolio with long term protection of proprietary manufacturing processes and critical technologies across the U.S., EU, and Asia.

AI 智慧專利圖示
Three Core Innovation Engines
Breath Actuated

Enables personalized precision medicine by optimizing aerosol output and lung deposition. Integrated with data driven monitoring to reduce drug waste and improve therapeutic outcomes.

Integrated Microfluidic Drug Device Platform

Propellant free microfluidic nozzle technology creates fine, controlled aerosol clouds through liquid-column impaction, enabling sustained-release inhalation therapies.

Separated Nebulization Design

Lower contamination risk, portable power compatibility, and flexible deployment for emergency and mobile healthcare scenarios.

AI Strategic IP Deployment

Strategic Patent Intelligence

Real time monitoring of technology trends and competitive dynamics enables precise patent positioning in forward looking fields, including smart nebulizers, specialized nebulization modules (e.g. high viscosity or high / Low shear drugs), and core components for industrial inkjet print heads.

Systematic analysis of product technology evolution and innovation pathways helps companies identify future opportunities in both red ocean and blue ocean markets.

Maintenance & Defensive Strategy

A global patent benchmarking and monitoring system supports cross border patent defense and risk tracking. AI-driven risk identification protects existing product advantages while reducing legal and commercial exposure.

From Patents to Profitable Innovation

Through an end-to-end CDMO (Contract Development and Manufacturing Organization) model covering R&D, process development, validation, regulatory submission, and market entry, MicroBase helps clients reduce development costs and technical risks, accelerate global regulatory approval, and transform innovation into commercially viable assets.

  • Global patent deployment secures technological leadership.
  • Reduces IP risks during scale-up.
  • Shortens time to market.
  • Increases commercialization success.

Building your global footprint now.